Drug metabolism in the lungs: opportunities for optimising inhaled medicines

Zachary Enlo-Scotta Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King’s College London, London, UK

Erica Bäckströmb Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Ian Mudwayc MRC Centre for Environment and Health, School of Population Health & Environmental Sciences, Imperial College London, London, United Kingdom; National Institute for Health Research, Health Protection Research Units in Chemical and Radiation Threats and Hazards and Environmental Exposures and Health, Imperial College London, London, UK

Ben Forbesa Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King’s College London, London, UKCorrespondence[email protected]

https://orcid.org/0000-0001-8193-6107

Drug metabolism in the lungs: opportunities for optimising inhaled medicines

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Drug metabolism in the lungs: opportunities for optimising inhaled medicines

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date